A recent study has examined the accuracy of the US Preventive Services Task Force (USPSTF) and American College of Cardiology/American Heart Association (ACC/AHA) recommendations for identifying African American individuals who would benefit from statins.
Advocacy, patient feedback encouraged during APhA keynote address.
Public perceptions on naloxone may differ by community.
At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.
Pharmacists play an important role in helping to deal with clinical inertia.
There are several new options coming down the pipeline for patients with type 2 diabetes.
Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.
There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.
Sessions focuses on new diabetes treatment options.
Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.
In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.
Failing to secure sufficient support for their proposed Affordable Care Act (ACA) replacement, Republicans leaders have pulled the American Health Care Act (AHCA) from the House floor, cancelling a scheduled vote on the health care legislation
In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The FDA granted accelerated approval to the first treatment for metastatic Merkel cell carcinoma (MCC).
New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.
Everybody seems to use social media, and pharmacists are no exception. However, it's been unclear how pharmacists employ social media in their daily professional practice.
The SpartanNash Foundation recently presented a $5,000 grant to Ruth Meiers Hospitality House of Bismarck, helping them to provide access to daily meals, laundry facilities, showers, computers, and case management services to the homeless and those at risk of homelessness in the community.
CVS Health, the University of Pittsburgh School of Pharmacy, and the Pittsburgh Public Schools have announced a unique public-private partnership that will bring CVS Health's prescription drug abuse prevention program to students in the Pittsburgh Public Schools.
The National Community Pharmacists Association (NCPA) is proud to announce a new strategic partnership with the PRS Pharmacy Services (PRS).
APhA is about to kick off and we'll be there all weekend covering it live!
The meningitis outbreak trial involving the New England Compounding Center (NECC) pharmacist Barry Cadden has reached a final verdict.
The composition of our classes has changed in many ways.
The US Veterans Administration (VA) health care system is the largest in the United States, serving 22 million former military members.
Eli Lilly and Company recently announced positive late-stage results in its clinical trial testing a combination of its experimental breast cancer drug and another widely-used treatment.
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
Have you ever considered pursuing a PGY-2 pharmacy residency in critcal care?
The FDA has approved Newron Pharmaceutical’s Xadago (safinamide), an add-on treatment for patients with Parkinson’s disease.
An estimated 86 million Americans have prediabetes, and 90% of them don't know they have it.
